目的：评价大黄类制剂（大黄或含有大黄的中药复方）治疗脓毒症急性胃肠功能损伤（AGI）的疗效。方法通过计算机检索美国国立医学图书馆PubMed、美国医学索引Medline、Cochrane 临床试验数据库、中国期刊全文数据库（CNKI）、中国生物医学文献数据库（CBM）、万方数据库、维普中文期刊数据库建库至2016年3月发表的关于大黄类制剂治疗脓毒症AGI的随机对照临床试验（RCT），同时检索纳入文献的参考文献。由两名研究人员分别独立检索、筛选文献，并独立对纳入文献运用Jadad量表进行质量评价和数据提取，采用Rev Man 5.3软件进行大黄类制剂对脓毒症AGI患者胃肠功能评分、急性生理学与慢性健康状况评分系统Ⅱ（APACHEⅡ）评分、28 d病死率影响的Meta分析，并绘制漏斗图评价文献发表的偏倚情况。结果①最终纳入16篇文献、共1171例患者，其中大黄类制剂治疗组610例，其中对照组561例；≥3分的文献12篇，＜3分的文献4篇；各研究均是随机入组并明确指出组间基线具有可比性；5篇文献使用了盲法。②大黄类制剂治疗组在改善胃肠功能评分〔均数差（MD）＝-0.52，95%可信区间（95%CI）＝-0.55～-0.48， P＜0.00001〕、降低APACHEⅡ评分（MD＝-3.66，95%CI＝-5.00～-2.33，P＜0.00001）和28 d病死率〔优势比（OR）＝0.46，95%CI＝0.30～0.71，P＜0.00001〕方面明显优于常规治疗对照组，差异有统计学意义。漏斗图显示，16篇文献不存在发表偏倚。结论大黄类制剂联合常规治疗可显著改善脓毒症AGI患者胃肠功能评分、降低APACHE Ⅱ评分和28 d病死率，且敏感性分析未能从实质上改变Meta分析的结果。%ObjectiveTo evaluate the effect of Rhubarb associated preparations (rhubarb or prescriptions of traditional Chinese medicine including rhubarb) on sepsis patients with acute gastrointestinal dysfunction (AGI).Methods The retrieval of databases from libraries including PubMed, Medline, Cochrane Central Register of Controlled Trials, CNKI, CBMdisc, Wan Fang Database, VIP database were searched to identify randomized controlled trials (RCTs) about Rhubarb associated preparations for treatment of sepsis patients with AGI from the foundation of the various databases to March 2016. And in the mean time, the references of the studies accepted were also retrieved. The retrieving and screening of literatures were performed independently by two researchers, the methodological quality and data extraction of the enrolled literatures were assessed by Jadad scale, and Cochrane Collaboration 5.3 software was used to perform Meta analyses to observe the effects of rhubarb associated preparations on gastrointestinal function score, acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ) score and 28-day mortality in sepsis patients with AGI; the bias of published literatures was evaluated by funnel plot.Results ① Finally, 16 studies involving 1 171 patients (610 in rhubarb preparation group and 561 in the control group) were identified and enrolled. 12 studies had a Jadad score ≥ 3 and 4 studies < 3. The random method was used in classification of groups in all the studies in which the intergroup baseline data being comparable was clearly indicated. The blind method was applied in 5 contained RCTs.② The results of Meta-analyses showed that rhubarb associated preparation could improve gastrointestinal function score [mean difference (MD) = -0.52, 95% confidence interval (95%CI) = -0.55 to -0.48, P < 0.000 01], reduce the APACHEⅡ score (MD = -3.66, 95%CI = -5.00 to -2.33,P < 0.000 01) and 28-day mortality [odds ratio (OR) = 0.46, 95%CI = 0.30 to 0.71,P < 0.000 01] compared with those in the control group, the differences being statistically significant. No publication bias was seen in 16 literatures containing RCTs from the funnel plot.Conclusions Compared with the control group, the rhubarb associated preparations combined with conventional theraph can significantly improve the gastrointestinal function score, reduce APACHE Ⅱ score and 28-day mortality of sepsis patients with AGI, which suggests the rhubarb associated preparations have better efficacy. In addition, the result of sensitivity analysis has not substantially changed the results of Meta-analysis.
展开▼
